Timothy Van Hauwermeiren

Insider Reports History

Location
C/O Iteos Therapeutics, Inc., 139 Main Street, Cambridge, MA
Signature
/s/ Tyler Nielsen, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Timothy Van Hauwermeiren:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Denali Therapeutics Inc. Director Common Stock 10.6K $154K $14.52 Nov 4, 2025 Direct
iTeos Therapeutics, Inc. Director Common Stock 22.3K $96.1K $4.30 May 13, 2025 Direct
Denali Therapeutics Inc. Director Stock Option (right to buy) 31.9K Nov 4, 2025 Direct
Lexeo Therapeutics, Inc. Director Stock Option (right to buy) 22.9K Jun 26, 2025 Direct
iTeos Therapeutics, Inc. Director Stock Option (Right to Buy) 0 May 13, 2025 Direct
RayzeBio, Inc. Director Stock Option (Right to Buy) 0 Feb 26, 2024 Direct

Insider Reports Filed by Timothy Van Hauwermeiren

Symbol Company Period Transactions Value $ Form Type Date Filed Role
DNLI Denali Therapeutics Inc. Nov 4, 2025 2 $0 4 Nov 6, 2025 Director
DNLI Denali Therapeutics Inc. Nov 4, 2025 0 $0 3 Nov 6, 2025 Director
LXEO Lexeo Therapeutics, Inc. Jun 26, 2025 1 $0 4 Jun 30, 2025 Director
ITOS iTeos Therapeutics, Inc. May 13, 2025 2 $96.1K 4 May 14, 2025 Director
LXEO Lexeo Therapeutics, Inc. Jul 5, 2024 1 $0 4 Jul 8, 2024 Director
LXEO Lexeo Therapeutics, Inc. Jul 5, 2024 0 $0 3 Jul 8, 2024 Director
ITOS iTeos Therapeutics, Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
RYZB RayzeBio, Inc. Feb 26, 2024 1 $0 4 Feb 27, 2024 Director
RYZB RayzeBio, Inc. Nov 1, 2023 1 $0 4 Nov 1, 2023 Director
RYZB RayzeBio, Inc. Nov 1, 2023 0 $0 3 Nov 1, 2023 Director
ITOS iTeos Therapeutics, Inc. Jun 13, 2023 1 $0 4 Jun 15, 2023 Director
ITOS iTeos Therapeutics, Inc. Jun 9, 2022 1 $0 4 Jun 10, 2022 Director
ITOS iTeos Therapeutics, Inc. Jun 17, 2021 1 $0 4 Jun 21, 2021 Director